Unclaimed brand
Precision therapy without the beam Contact Us Innovating Localized Radiation Therapy Pancreatic cancer survivor discusses CivaSheet® Implant
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#008FD4
Cerulean
0, 143, 212
200, 100, 42
100, 33, 0, 17
#E6DB55
Confetti
230, 219, 85
55, 74, 62
0, 5, 63, 10
#804E0F
Korma
128, 78, 15
33, 79, 28
0, 39, 88, 50
CivaTech Oncology Inc. is a North Carolina-based company developing and commercializing polymer-based low-dose-rate brachytherapy devices for cancer treatment. Its products are designed to deliver localized radiation while supporting individualized therapy and integration with established clinical workflows, from imaging and treatment planning through post-implant dosimetry.
The portfolio includes CivaString®, a linear, polymer-encapsulated radiation source for localized solid tumors; CivaSheet®, a flexible, bioabsorbable planar source that delivers directional radiation; and CivaDerm™, a temporary product for intraoperative or surface radiation treatment of skin cancer and other lesions. CivaTech says its devices can help reduce procedure time, provide more homogeneous dose distribution, and minimize tissue trauma. CivaString® and CivaSheet® are FDA-cleared for treating solid tumors, with potential applications that include prostate, pancreatic, colorectal, gynecological, lung, and other cancers. CivaSheet® is described as the only FDA-cleared unidirectional planar brachytherapy source. The company also provides information and resources for medical professionals and patients, including product details, clinical presentations, and treatment guidance.
